Sutro Biopharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sutro Biopharma Stock Summary

Sutro Biopharma competes with Vaxcyte, Larimar Therapeutics, Syndax Pharmaceuticals, Merus BV, and Ideaya Biosciences. Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California. Sutro Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.

Sutro Biopharma Key Financial Ratios

Sutro Biopharma Key Balance Sheet Accounts

Sutro Biopharma Key Income Statement Accounts

Sutro Biopharma Key Cash Accounts

Sutro Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sutro Biopharma's current stock value. Our valuation model uses many indicators to compare Sutro Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sutro Biopharma competition to find correlations between indicators driving Sutro Biopharma's intrinsic value. More Info.Sutro Biopharma is rated below average in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Sutro Biopharma's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sutro Biopharma's earnings, one of the primary drivers of an investment's value.

Sutro Biopharma Systematic Risk

Today, most investors in Sutro Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sutro Biopharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sutro Biopharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sutro Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sutro Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sutro Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Sutro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sutro Biopharma's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.